NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Synlogic Inc (NASDAQ: SYBX)
SYBX Technical Analysis
5
As on 9th Jun 2023 SYBX STOCK Price closed @ 0.59 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.44 & Strong Sell for SHORT-TERM with Stoploss of 2.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SYBXSTOCK Price
Open | 0.58 | Change | Price | % |
High | 0.63 | 1 Day | 0.00 | 0.00 |
Low | 0.57 | 1 Week | 0.07 | 13.46 |
Close | 0.59 | 1 Month | 0.07 | 13.46 |
Volume | 198363 | 1 Year | -1.80 | -75.31 |
52 Week High 2.55 | 52 Week Low 0.49 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
SYBX Daily Charts |
SYBX Intraday Charts |
Whats New @ Bazaartrend |
SYBX Free Analysis |
|
SYBX Important Levels Intraday
RESISTANCE | 0.71 |
RESISTANCE | 0.67 |
RESISTANCE | 0.65 |
RESISTANCE | 0.62 |
SUPPORT | 0.56 |
SUPPORT | 0.53 |
SUPPORT | 0.51 |
SUPPORT | 0.47 |
SYBX Forecast May 2024
4th UP Forecast | 2.4 |
3rd UP Forecast | 1.82 |
2nd UP Forecast | 1.46 |
1st UP Forecast | 1.1 |
1st DOWN Forecast | 0.08 |
2nd DOWN Forecast | -0.28 |
3rd DOWN Forecast | -0.64 |
4th DOWN Forecast | -1.22 |
SYBX Weekly Forecast
4th UP Forecast | 1.15 |
3rd UP Forecast | 0.97 |
2nd UP Forecast | 0.86 |
1st UP Forecast | 0.75 |
1st DOWN Forecast | 0.43 |
2nd DOWN Forecast | 0.32 |
3rd DOWN Forecast | 0.21 |
4th DOWN Forecast | 0.03 |
SYBX Forecast2024
4th UP Forecast | 4.83 |
3rd UP Forecast | 3.47 |
2nd UP Forecast | 2.63 |
1st UP Forecast | 1.79 |
1st DOWN Forecast | -0.61 |
2nd DOWN Forecast | -1.45 |
3rd DOWN Forecast | -2.29 |
4th DOWN Forecast | -3.65 |
Synlogic Inc ( NASDAQ USA Symbol : SYBX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SYBX Other Details
Segment | EQ | |
Market Capital | 173796160.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
SYBX Address
SYBX Latest News
SYBX Business Profile
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase II clinical trial to treat phenylketonuria (PKU), as well as pre-clinical stage product SYNB1934 for the treatment of PKU; and SYNB8802 that is in Phase I clinical trial for the treatment of Enteric Hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service